Facial Yoga Toning Program - A Pilot Study

This study has been terminated.
(Investigator no longer at Cleveland Clinic)
Sponsor:
Information provided by:
The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00952549
First received: August 4, 2009
Last updated: January 15, 2010
Last verified: January 2010
  Purpose

The primary objective of this study is to determine the efficacy of a facial yoga exercise program on appearance and to measure patient satisfaction with facial yoga practice.


Condition Intervention Phase
Facial Atrophy Related to Age
Procedure: Facial Yoga Toning Program
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Facial Yoga Toning Program - A Pilot Study

Further study details as provided by The Cleveland Clinic:

Primary Outcome Measures:
  • Clinical evaluations will be performed at each follow-up visit: 2 weeks, 4 weeks, 6 weeks and 8 weeks. Level of improvement will be quantified using the Global Aesthetic Improvement Scale. [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Secondary measures at each visit will also include level of subject satisfaction with the program and subject's assessment of any improvement in their overall appearance (based on the scale above). [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Enrollment: 0
Study Start Date: August 2009
Study Completion Date: September 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Facial Yoga Toning Program
    Patients will be instructed on 18 exercises which are intended to strengthen and tone the muscles of facial expression. DVD is provided.
Detailed Description:

This is a single center prospective longitudinal pilot study of 27 subjects. The study will include 20 study subjects and 7 controls. Participants in this study will be healthy subjects 18 years and older with mild to moderate facial atrophy without a history of surgical or non-surgical treatment to the area. The study subjects will perform facial yoga and apply sunscreen (Neutrogena Helioplex SPF 55) daily. The controls will apply sunscreen alone daily for 8 weeks.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • over age 18 years

Exclusion Criteria:

  • pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00952549

Sponsors and Collaborators
The Cleveland Clinic
Investigators
Principal Investigator: Rebecca Tung, MD The Cleveland Clinic
Principal Investigator: Wilma Bergfeld, MD The Cleveland Clinic
  More Information

No publications provided

Responsible Party: Tung, Rebecca, Cleveland Clinic
ClinicalTrials.gov Identifier: NCT00952549     History of Changes
Other Study ID Numbers: FYTP
Study First Received: August 4, 2009
Last Updated: January 15, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Facies
Atrophy
Disease Attributes
Pathologic Processes
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on September 15, 2014